ASTRIA THERAPEUTICS INC (ATXS) Stock Income Statement
NASDAQ:ATXS - Nasdaq - US04635X1028 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Operating Expenses | 124.40M | 111.56M | 67.83M | 53.50M | 194.98M | |||
| Research and Development | 89.17M | 77.11M | 42.13M | 34.26M | 180.17M | |||
| Selling, General, and Administrative Expenses | 35.24M | 34.45M | 25.70M | 19.24M | 14.81M | |||
| Operating Income | -124.40M | -111.56M | -67.83M | -53.50M | -194.98M | |||
| Interest Income/Expense | 16.46M | 17.36M | 10.20M | 1.72M | 120.00K | |||
| Other Income/Expense | -103.00K | -62.00K | -62.00K | -60.00K | -60.00K | |||
| Non Recurring Items | N/A | N/A | -15.20M | N/A | N/A | |||
| Income Before Taxes | -108.04M | -94.26M | -72.89M | -51.83M | -194.91M | |||
| Income Tax | N/A | N/A | N/A | N/A | N/A | |||
| Net Income | -108.04M | -94.26M | -72.89M | -51.83M | -219.35M | |||
| EBITDA | N/A | N/A | N/A | N/A | N/A | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -1.87 | -1.68 | -2.42 | -3.55 | -24.58 | |||
| Non GAAP EPS | -1.63 | -1.43 | -2.42 | -3.63 | -14.31 | |||
| Statistics | ||||||||
| Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
| Operating Profit Margin | N/A | N/A | N/A | N/A | N/A | |||
All data in USD